These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 32498686

  • 1. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
    Chang FY, Chen HC, Chen PJ, Ho MS, Hsieh SL, Lin JC, Liu FT, Sytwu HK.
    J Biomed Sci; 2020 Jun 04; 27(1):72. PubMed ID: 32498686
    [Abstract] [Full Text] [Related]

  • 2. The COVID-19 pandemic.
    Ciotti M, Ciccozzi M, Terrinoni A, Jiang WC, Wang CB, Bernardini S.
    Crit Rev Clin Lab Sci; 2020 Sep 04; 57(6):365-388. PubMed ID: 32645276
    [Abstract] [Full Text] [Related]

  • 3. COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies.
    Bergmann CC, Silverman RH.
    Cleve Clin J Med; 2020 Jun 04; 87(6):321-327. PubMed ID: 32366502
    [No Abstract] [Full Text] [Related]

  • 4. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
    Nowill AE, de Campos-Lima PO.
    J Immunol; 2020 Nov 15; 205(10):2566-2575. PubMed ID: 32958687
    [Abstract] [Full Text] [Related]

  • 5. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.
    Ni L, Ye F, Cheng ML, Feng Y, Deng YQ, Zhao H, Wei P, Ge J, Gou M, Li X, Sun L, Cao T, Wang P, Zhou C, Zhang R, Liang P, Guo H, Wang X, Qin CF, Chen F, Dong C.
    Immunity; 2020 Jun 16; 52(6):971-977.e3. PubMed ID: 32413330
    [Abstract] [Full Text] [Related]

  • 6. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
    Khadke S, Ahmed N, Ahmed N, Ratts R, Raju S, Gallogly M, de Lima M, Sohail MR.
    Virol J; 2020 Oct 15; 17(1):154. PubMed ID: 33059711
    [Abstract] [Full Text] [Related]

  • 7. [COVID-19- what have we learned and where are we heading?].
    Gudnason T.
    Laeknabladid; 2020 Oct 15; 106(10):449. PubMed ID: 32991305
    [No Abstract] [Full Text] [Related]

  • 8. COVID-19: a conundrum to decipher.
    Deshmukh V, Tripathi SC, Pandey A, Deshmukh V, Vykoukal J, Patil A, Sontakke B.
    Eur Rev Med Pharmacol Sci; 2020 May 15; 24(10):5830-5841. PubMed ID: 32495923
    [Abstract] [Full Text] [Related]

  • 9. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
    Cunha LL, Perazzio SF, Azzi J, Cravedi P, Riella LV.
    Front Immunol; 2020 May 15; 11():1748. PubMed ID: 32849623
    [Abstract] [Full Text] [Related]

  • 10. Early Insights into Immune Responses during COVID-19.
    St John AL, Rathore APS.
    J Immunol; 2020 Aug 01; 205(3):555-564. PubMed ID: 32513850
    [Abstract] [Full Text] [Related]

  • 11. Immunology of COVID-19: Current State of the Science.
    Vabret N, Britton GJ, Gruber C, Hegde S, Kim J, Kuksin M, Levantovsky R, Malle L, Moreira A, Park MD, Pia L, Risson E, Saffern M, Salomé B, Esai Selvan M, Spindler MP, Tan J, van der Heide V, Gregory JK, Alexandropoulos K, Bhardwaj N, Brown BD, Greenbaum B, Gümüş ZH, Homann D, Horowitz A, Kamphorst AO, Curotto de Lafaille MA, Mehandru S, Merad M, Samstein RM, Sinai Immunology Review Project.
    Immunity; 2020 Jun 16; 52(6):910-941. PubMed ID: 32505227
    [Abstract] [Full Text] [Related]

  • 12. Multiple sclerosis and COVID-19.
    Mares J, Hartung HP.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Sep 16; 164(3):217-225. PubMed ID: 32686774
    [Abstract] [Full Text] [Related]

  • 13. SARS-CoV-2-A Tough Opponent for the Immune System.
    Nasab MG, Saghazadeh A, Rezaei N.
    Arch Med Res; 2020 Aug 16; 51(6):589-592. PubMed ID: 32532524
    [Abstract] [Full Text] [Related]

  • 14. Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge.
    Papachristodoulou E, Kakoullis L, Parperis K, Panos G.
    Pathog Dis; 2020 Apr 01; 78(3):. PubMed ID: 32510562
    [Abstract] [Full Text] [Related]

  • 15. Cytokine storm and the prospects for immunotherapy with COVID-19.
    Calabrese LH.
    Cleve Clin J Med; 2020 Jun 30; 87(7):389-393. PubMed ID: 32393592
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. SARS-CoV-2: the emergence of a viral pathogen causing havoc on human existence.
    Prasad A, Prasad M.
    J Genet; 2020 Jun 30; 99(1):. PubMed ID: 32482926
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic.
    Lu X, Xiang Y, Du H, Wing-Kin Wong G.
    Pediatr Allergy Immunol; 2020 Jul 30; 31(5):449-453. PubMed ID: 32330332
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.